Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-028165

Chief Executive Officer sold 2,000 shares at $249.67 ($499,330)

  • Chief Executive Officer gave 2,000 shares (gift)
  • Chief Executive Officer gave 2,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2024-11-27 Gift −2,000 2,090 I
Farrell Michael J. Chief Executive Officer 2024-11-27 Gift +2,000 2,000 I
Farrell Michael J. Chief Executive Officer 2024-11-27 Sale −2,000 $249.67 $499,330 0 I
Derivatives
Farrell Michael J. Chief Executive Officer 2024-11-25 Grant or award · ResMed Common Stock Options +33,036 $249.56 $8,244,464 33,036 D
Open-market sales · 2,000 sh · avg $249.67 · $499,330
Loading xslF345X05/form4.xml…